Abbott (ABT) Q1 Earnings Beat Estimates, Margins Contract

Abbott Laboratories (ABT) reported first-quarter 2024 adjusted earnings per share (EPS) of 98 cents, which topped the Zacks Consensus Estimate by 2.1%. However, the adjusted figure decreased 4.9% from the prior-year quarter’s level. The quarter’s adjustments include 28 cents of certain non-recurring items.GAAP EPS came in at 70 cents, down 6.7% year over year.First-quarter worldwide sales of $9.96 billion were up 2.2% year over year on a reported basis. The top line exceeded the Zacks Consensus Estimate by ...